Journal article
Definition and identification of patients with treatment-resistant depression in real-world clinical practice settings across asia
C Han, G Wang, S Chan, T Kato, CH Ng, W Tan, L Zhang, Y Feng, CY Liu
Neuropsychiatric Disease and Treatment | DOVE MEDICAL PRESS LTD | Published : 2020
DOI: 10.2147/NDT.S264799
Open access
Abstract
Purpose: An Asia-Pacific expert consensus defined treatment-resistant depression (TRD) as failure of ≥2 antidepressants given at adequate doses for 6–8 weeks during a major depressive episode. A survey examined how TRD was being diagnosed in real-world practices across Asia. An expert panel then interpreted the results and provided practical recommendations. Methods: Between March and July 2018, 246 clinicians from Hong Kong, Japan, Mainland China, South Korea, and Taiwan were surveyed on how they identified TRD patients according to their own definitions. Results: Most physicians described antidepressant failure as “no response” (79%) or “inadequate response” (82%); fewer chose “failure to ..
View full abstractGrants
Funding Acknowledgements
Janssen Pharmaceuticals Asia-Pacific provided funding for the data collection.